American Brain Tumor Association Names New Development Director

Printer Friendly

September 17, 2015

Chicago, Ill., September 17, 2015 – The American Brain Tumor Association (ABTA) is pleased to announce Debbie Robins, CFRE, as its new development director.  Robins brings more than 20 years of nonprofit experience to the ABTA most recently serving as the grant and compliance manager for the College of American Pathologists.

“Debbie is an extraordinary addition to the ABTA, as she joins us with a proven track record in fundraising for health and human service organizations and strong experience in scientific grants administration,” said Elizabeth M. Wilson, president and CEO, American Brain Tumor Association. “We are thrilled to have a leader of Debbie’s caliber join our team and help us achieve our fundraising potential and advance our mission.”

Prior to joining the ABTA, Robins was responsible for enterprise-wide grant efforts that included grant and contract research, collaboration/partnership development, application process, reporting and compliance on federal and private grants and government contracts for the College of American Pathologists (CAP) and the CAP Foundation.  

“I was attracted to the ABTA’s mission and the commitment the staff have to truly improve the lives of everyone touched by a brain tumor diagnosis,” said Robins.  “I believe that through the ABTA’s national expansion, more people will become engaged with the cause and support our efforts which is the greatest hope we have for ultimately transforming the brain tumor experience.”

Robins holds a master’s degree in Nonprofit Management from Spertus Institute of Jewish Studies and a B.S. in Social Science from Northeastern Illinois University.  She also holds the Certified Fund Raising Executive (CFRE) designation from the Association for Fundraising Professionals.


Founded in 1973, the American Brain Tumor Association was first and is now the only national organization committed to funding brain tumor research and providing education and information on all tumor types and for all age groups. For more information, visit or call 800-886-ABTA (2282).

# # #

CONTACT: Julie Landmesser